After steadily increasing its own coronavirus testing capacity, UC Davis Health is now collaborating with the state to quickly and significantly boost California’s testing capacity, as announced Saturday (April 4) by Gov. Gavin Newsom.

Dean Allison Brashear of the UC Davis School of Medicine said the university “is pleased to partner with Gov. Newsom on this important effort to increase testing capacity for Northern Californians.”

(SACRAMENTO) —

UC Davis Health is honored to be part of Gov. Gavin Newsom’s COVID-19 Testing Task Force, a public-private collaboration to more quickly increase coronavirus testing capacity.

(SACRAMENTO) — Clinical pathologists, infectious disease physicians and scientists at UC Davis Health are collaborating on new reagents (substances used for chemical analysis), diagnostic tests and a vaccine for the COVID-19 coronavirus in hopes of preventing and ultimately treating the infection.

The economy could be suffering the effects of the coronavirus for decades, suggest economists at the University of California, Davis, who researched the financial effects of pandemics dating back to the 14th century. “If the trends play out similarly in the wake of COVID-19 — adjusted to the scale of this pandemic — the global economic trajectory will be very different than was expected only a few weeks ago,” the authors wrote in a working paper published this week

Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis. Although it’s not yet known how important this is to the spread of COVID-19, it underscores the need for strict social distancing measures — and for virologists, epidemiologists and engineers who study aerosols and droplets to work together on this and other respiratory diseases. 

As SARS-CoV-2 has spread around the world, its transmission rate has varied alongside variations in its genome, according to researchers at the University of California, Davis. Surveillance of the virus genome may help public authorities target areas about to experience an upsurge of infection. 

PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.

A blood test result more typically seen in disorders associated with bone marrow diseases was found in a patient with COVID-19, a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings were published March 25 in the American Journal of Hematology. 

COVID-19 Research Virtual Town Halls will be held from 10:30 to 11:30 a.m. every Friday starting April 3, The forum for campus researchers will be moderated by Allison Brashear, dean of the School of Medicine, and Prasant Mohapatra, vice chancellor of research.